7 powodów, dla których warto stosować difenhydraminę w łagodzeniu przejściowych zaburzeń snu Artykuł przeglądowy
##plugins.themes.bootstrap3.article.sidebar##
Opublikowane:
gru 31, 2019
Słowa kluczowe:
difenhydramina, leczenie bezsenności, łagodna przejściowa bezsenność
##plugins.themes.bootstrap3.article.main##
Abstrakt
Difenhydramina jest lekiem przeciwhistaminowym I generacji o działaniu sedatywnym. Z tego powodu rozważa się ją jako alternatywną opcję w farmakologicznym leczeniu przejściowych zaburzeń snu. Nie ma potencjału uzależniającego i w niektórych krajach jest dostępna bez recepty.
##plugins.themes.bootstrap3.article.details##
Jak cytować
Skalski, M. (2019). 7 powodów, dla których warto stosować difenhydraminę w łagodzeniu przejściowych zaburzeń snu . Medycyna Faktów , 12(4(45), 318-322. https://doi.org/10.24292/01.MF.0419.2
Numer
Dział
Artykuły
Copyright © by Medical Education. All rights reserved.
Bibliografia
1. Carruthers S.G., Shoeman D.W., Hignite C.E., Azarnoff D.L.: Correlation between plasma diphenhydramine level and sedative and antihistamine effects. Clin. Pharm. Ther. 1978; 23(4): 375-382.
2. Glazko A.J., Dill W.A., Young R.M. et al.: Metabolic disposition of diphenhydramine. Clin. Pharmacol. Ther. 1974; 16(6): 1066-1076.
3. Simons F.E.R., Simons K.J.: Histamine and H1-antihistamines: Celebrating a century of progress. J. Allergy Clin. Immunol. 2011; 128(6): 1139-1150.e4.
4. Skalski M.: Zaburzenia snu w codziennej praktyce. Wyd. 2. Medical Tribune, Warszawa 2018.
5. Cooper S., Laurora I., Wang Y. et al.: Efficacy and tolerability studies evaluating a sleep aid and analgesic combination of naproxen sodium and diphenhydramine in the dental impaction pain model in subjects with induced transient insomnia. Int. J. Clin. Pract. 2015; 69(10): 1149-1158.
6. Kudo Y., Kurihara M.: Clinical evaluation of diphenhydramine hydrochloride for the treatment of insomnia in psychiatric patients: a double- blind study. J. Clin. Pharmacol. 1990; 30(11): 1041-1048.
7. Morin C.M., Koette U., Bastien C. et al.: Valerian-hops combination and diphenhydramine for treating insomnia: a randomized placebo-controlled clinical trial. Sleep 2005; 28(11): 1465-1471.
8. Rickels K., Morris R.J., Newman H. et al.: Diphenhydramine in insomniac family practice patients: a double-blind study. J. Clin. Pharmacol. 1983; 23(5-6): 234-242.
9. Gengo F.M., Manning C.: A review of the effects of antihistamines on mental processes related to automobile driving. J. Allergy Clin. Immunol. 1990; 86(6): 1034-1039.
10. Ramaekers J.G., O’Hanlon J.F.: Acrivastine, terfenadine and diphenhydramine effects on driving performance as a function of dose and time after dosing. Eur. J. Clin. Pharmacol. 1994; 47(3): 261-266.
11. Verster J.C., de Veert A.M., Bijtjes S.I. et al.: Driving ability after acute and sub-chronic administration of levocetirizine and diphenhydramine: a randomized, double-blind, placebo-controlled trial. Psychopharmacology 2003; 169(1): 84-90.
12. [online: www.leki-informacje.pl].
13. Apap Noc – ulotka – Rejestr produktów leczniczych. Dostęp: 3.06.2019.
14. Culpepper L., Wingertzahn M.A.: Over-the-Counter Agents for the Treatment of Occasional Disturbed Sleep or Transient Insomnia: A Systematic Review of Efficacy and Safety. Prim. Care Companion. CNS Disord. 2015; 17(6): 10.4088/PCC.15r01798. DOI: 10.4088/PCC.15r01798.
15. Friedman B.W., Cabral L., Adevunmi V. et al.: Diphenhydramine as Adjuvant Therapy for Acute Migraine: An Emergency Department-Based Randomized Clinical Trial. Ann. Emerg. Med. 2016; 67(1): 32-39.e3.
16. Lin R.Y., Curry A., Pesola G.R. et al.: Improved outcomes in patients with acute allergic syndromes who are treated with combined H1 and H2 antagonists. Ann. Emerg. Med. 2000; 36(5): 462-468.
17. Paul I.M., Yoder K.E., Crowell K.R. et al.: Effect of dextromethorphan, diphenhydramine, and placebo on nocturnal cough and sleep quality for coughing children and their parents. Pediatrics 2004; 114(1): e85-90.
18. Swidan S.Z., Lake A.E., Saper J.R.: Efficacy of intravenous diphenhydramine versus intravenous DHE-45 in the treatment of severe migraine headache. Curr. Pain Head. Rep. 2005; 9(1): 65-70.
19. Thormann M., Amthauer H., Adolf D. et al.: Efficacy of diphenhydramine in the prevention of vertigo and nausea at 7 T MRI. Eur. J. Radiol. 2013; 82(5): 768-772.
20. Yoder K.E., Shaffer M.L., La Tournous S.J., Paul I.M.: Child Assessment of Dextromethorphan, Diphenhydramine, and Placebo for Nocturnal Cough Due to Upper Respiratory Infection. Clin. Pediatr. 2006; 45(7): 633-640.
21. Cengiz M., Baysal Z., Ganidagli S.: Oral sedation with midazolam and diphenhydramine compared with midazolam alone in children undergoing magnetic resonance imaging. Paediatr. Anaesth. 2006; 16(6): 621-626.
22. Glass J.R., Sproule B.A., Herrmann N., Busto U.E.: Effects of 2-week treatment with temazepam and diphenhydramine in elderly insomniacs: a randomized, placebo-controlled trial. J. Clin. Psychopharmacol. 2008; 28(2): 182-188.
23. Hryniewicz W., Albrecht P., Radzikowski A. (red.): Narodowy Program Ochrony Antybiotyków. Rekomendacje postępowania w zakażeniach układu oddechowego. Narodowy Program Ochrony Antybiotyków. Warszawa 2016.
24. Merenstein D., Diener-West M., Halbower A.C. et al.: The trial of infant response to diphenhydramine: the TIRED study – a randomized, controlled, patient-oriented trial. Arch. Pediatr. Adolesc. Med. 2006; 160(7): 707-712.
25. Yangzom N., Gottschlich M.M., Ossege J. et al.: The Effect of Diphenhydramine on Sleep in Pediatric Burn Patients: A Secondary Analysis. J. Burn Care Res. 2015; 36(2): 266-271.
2. Glazko A.J., Dill W.A., Young R.M. et al.: Metabolic disposition of diphenhydramine. Clin. Pharmacol. Ther. 1974; 16(6): 1066-1076.
3. Simons F.E.R., Simons K.J.: Histamine and H1-antihistamines: Celebrating a century of progress. J. Allergy Clin. Immunol. 2011; 128(6): 1139-1150.e4.
4. Skalski M.: Zaburzenia snu w codziennej praktyce. Wyd. 2. Medical Tribune, Warszawa 2018.
5. Cooper S., Laurora I., Wang Y. et al.: Efficacy and tolerability studies evaluating a sleep aid and analgesic combination of naproxen sodium and diphenhydramine in the dental impaction pain model in subjects with induced transient insomnia. Int. J. Clin. Pract. 2015; 69(10): 1149-1158.
6. Kudo Y., Kurihara M.: Clinical evaluation of diphenhydramine hydrochloride for the treatment of insomnia in psychiatric patients: a double- blind study. J. Clin. Pharmacol. 1990; 30(11): 1041-1048.
7. Morin C.M., Koette U., Bastien C. et al.: Valerian-hops combination and diphenhydramine for treating insomnia: a randomized placebo-controlled clinical trial. Sleep 2005; 28(11): 1465-1471.
8. Rickels K., Morris R.J., Newman H. et al.: Diphenhydramine in insomniac family practice patients: a double-blind study. J. Clin. Pharmacol. 1983; 23(5-6): 234-242.
9. Gengo F.M., Manning C.: A review of the effects of antihistamines on mental processes related to automobile driving. J. Allergy Clin. Immunol. 1990; 86(6): 1034-1039.
10. Ramaekers J.G., O’Hanlon J.F.: Acrivastine, terfenadine and diphenhydramine effects on driving performance as a function of dose and time after dosing. Eur. J. Clin. Pharmacol. 1994; 47(3): 261-266.
11. Verster J.C., de Veert A.M., Bijtjes S.I. et al.: Driving ability after acute and sub-chronic administration of levocetirizine and diphenhydramine: a randomized, double-blind, placebo-controlled trial. Psychopharmacology 2003; 169(1): 84-90.
12. [online: www.leki-informacje.pl].
13. Apap Noc – ulotka – Rejestr produktów leczniczych. Dostęp: 3.06.2019.
14. Culpepper L., Wingertzahn M.A.: Over-the-Counter Agents for the Treatment of Occasional Disturbed Sleep or Transient Insomnia: A Systematic Review of Efficacy and Safety. Prim. Care Companion. CNS Disord. 2015; 17(6): 10.4088/PCC.15r01798. DOI: 10.4088/PCC.15r01798.
15. Friedman B.W., Cabral L., Adevunmi V. et al.: Diphenhydramine as Adjuvant Therapy for Acute Migraine: An Emergency Department-Based Randomized Clinical Trial. Ann. Emerg. Med. 2016; 67(1): 32-39.e3.
16. Lin R.Y., Curry A., Pesola G.R. et al.: Improved outcomes in patients with acute allergic syndromes who are treated with combined H1 and H2 antagonists. Ann. Emerg. Med. 2000; 36(5): 462-468.
17. Paul I.M., Yoder K.E., Crowell K.R. et al.: Effect of dextromethorphan, diphenhydramine, and placebo on nocturnal cough and sleep quality for coughing children and their parents. Pediatrics 2004; 114(1): e85-90.
18. Swidan S.Z., Lake A.E., Saper J.R.: Efficacy of intravenous diphenhydramine versus intravenous DHE-45 in the treatment of severe migraine headache. Curr. Pain Head. Rep. 2005; 9(1): 65-70.
19. Thormann M., Amthauer H., Adolf D. et al.: Efficacy of diphenhydramine in the prevention of vertigo and nausea at 7 T MRI. Eur. J. Radiol. 2013; 82(5): 768-772.
20. Yoder K.E., Shaffer M.L., La Tournous S.J., Paul I.M.: Child Assessment of Dextromethorphan, Diphenhydramine, and Placebo for Nocturnal Cough Due to Upper Respiratory Infection. Clin. Pediatr. 2006; 45(7): 633-640.
21. Cengiz M., Baysal Z., Ganidagli S.: Oral sedation with midazolam and diphenhydramine compared with midazolam alone in children undergoing magnetic resonance imaging. Paediatr. Anaesth. 2006; 16(6): 621-626.
22. Glass J.R., Sproule B.A., Herrmann N., Busto U.E.: Effects of 2-week treatment with temazepam and diphenhydramine in elderly insomniacs: a randomized, placebo-controlled trial. J. Clin. Psychopharmacol. 2008; 28(2): 182-188.
23. Hryniewicz W., Albrecht P., Radzikowski A. (red.): Narodowy Program Ochrony Antybiotyków. Rekomendacje postępowania w zakażeniach układu oddechowego. Narodowy Program Ochrony Antybiotyków. Warszawa 2016.
24. Merenstein D., Diener-West M., Halbower A.C. et al.: The trial of infant response to diphenhydramine: the TIRED study – a randomized, controlled, patient-oriented trial. Arch. Pediatr. Adolesc. Med. 2006; 160(7): 707-712.
25. Yangzom N., Gottschlich M.M., Ossege J. et al.: The Effect of Diphenhydramine on Sleep in Pediatric Burn Patients: A Secondary Analysis. J. Burn Care Res. 2015; 36(2): 266-271.